Major Deal in the Pharmaceutical Sector in the USA

» Published: January 13 2025

Major Deal in the Pharmaceutical Sector in the USA
Photo: Richard Drew/AP/TT

The American pharmaceutical and medical technology giant Johnson & Johnson has made an agreement to buy the biomedicine company Intra-Cellular Therapies.

Johnson & Johnson's bid is 132 dollars per share, which means a valuation of Intra-Cellular of around 14.6 billion dollars (approximately 165 billion kronor).

Intra-Cellular specializes in developing treatments for patients with disorders in the central nervous system.

Loading related articles...

Tags

TTT
By TTTranslated and adapted by Sweden Herald
Loading related posts...